# FDA Inspection 1122513 - Kofinas Fertility Group - February 13, 2020

Source: https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/12bd4e9a-818b-449b-9c8b-430e6e47cde4
Source feed: FDA_Inspections

> FDA Inspection 1122513 for Kofinas Fertility Group on February 13, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122513
- Company Name: Kofinas Fertility Group
- Inspection Date: 2020-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266536 - 2025-04-09](https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/8a9b4743-be1b-4642-9c9b-87b34126e8f8)
- [FDA Inspection 1210757 - 2023-07-25](https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/e863db4a-95a3-47a2-b7e2-ac3733858e48)
- [FDA Inspection 1210757 - 2023-07-25](https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/a7f875d9-397c-4a5e-8f0d-cafa3a34bafb)
- [FDA Inspection 1122513 - 2020-02-13](https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/ce6d1974-d3b6-4e6c-ab04-1750df4f974c)
- [FDA Inspection 1056801 - 2018-06-25](https://www.keypedia.com/records/fda_inspections/kofinas-fertility-group/6d2c9f5d-8e35-4b46-96d8-f5439e92d308)

Company: https://www.keypedia.com/companies/kofinas-fertility-group/09d3a33d-78bd-4b53-9d89-474a34b3aecf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d